- Home
- BVFL vs SGMO Comparison
BVFL vs SGMO Comparison
Compare BVFL & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- SGMO
- Stock Information
- Founded
- BVFL 1873
- SGMO 1995
- Country
- BVFL United States
- SGMO United States
- Employees
- BVFL N/A
- SGMO N/A
- Industry
- BVFL Savings Institutions
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BVFL Finance
- SGMO Health Care
- Exchange
- BVFL Nasdaq
- SGMO Nasdaq
- Market Cap
- BVFL 205.3M
- SGMO 180.5M
- IPO Year
- BVFL N/A
- SGMO 2000
- Fundamental
- Price
- BVFL $17.30
- SGMO $2.51
- Analyst Decision
- BVFL
- SGMO Buy
- Analyst Count
- BVFL 0
- SGMO 3
- Target Price
- BVFL N/A
- SGMO $7.00
- AVG Volume (30 Days)
- BVFL 56.0K
- SGMO 7.3M
- Earning Date
- BVFL 01-21-2025
- SGMO 11-12-2024
- Dividend Yield
- BVFL N/A
- SGMO N/A
- EPS Growth
- BVFL N/A
- SGMO N/A
- EPS
- BVFL 1.20
- SGMO N/A
- Revenue
- BVFL $38,028,000.00
- SGMO $52,291,000.00
- Revenue This Year
- BVFL N/A
- SGMO N/A
- Revenue Next Year
- BVFL N/A
- SGMO $11.46
- P/E Ratio
- BVFL $14.50
- SGMO N/A
- Revenue Growth
- BVFL 0.50
- SGMO N/A
- 52 Week Low
- BVFL $10.14
- SGMO $0.30
- 52 Week High
- BVFL $18.19
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- BVFL 55.84
- SGMO 55.54
- Support Level
- BVFL $17.52
- SGMO $2.24
- Resistance Level
- BVFL $18.19
- SGMO $2.82
- Average True Range (ATR)
- BVFL 0.44
- SGMO 0.28
- MACD
- BVFL -0.05
- SGMO 0.02
- Stochastic Oscillator
- BVFL 38.16
- SGMO 52.88
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. It offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, business checking as well as certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.